{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:35Z","timestamp":1793146595220,"version":"4.5.0"},"reference-count":94,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1080\/14737175.2024.2434079","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:46:39Z","timestamp":1733150799000},"page":"1141-1155","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-1346","authenticated-orcid":false,"given":"Lars","family":"Edvinsson","sequence":"first","affiliation":[{"name":"Department of Medicine, Institute of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01208-0"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000199"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720963680"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01644-8"},{"key":"e_1_3_5_10_1","unstructured":"Pfizer Inc. Nurtec ODT (rimegepant) prescribing information. US food and drug administration. 2020 [updated 2023 Apr; cited 2024 Sep 4]; Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19036"},{"key":"e_1_3_5_11_1","unstructured":"Pfizer Inc. Zavzpret (zavegepant) prescribing information. US Food and Drug Administration. 2023 Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19471"},{"key":"e_1_3_5_12_1","unstructured":"AbbVie Inc. Ubrelvy (ubrogepant) prescribing information. US food and drug administration. 2019 [updated 2023 Jun; cited 2024 Sep 4]; Available from: https:\/\/www.rxabbvie.com\/pdf\/ubrelvy_pi.pdf"},{"key":"e_1_3_5_13_1","unstructured":"Teva Pharmaceuticals USA Inc. Ajovy (fremanezumab) prescribing information. US food and drug administration. 2018 [updated 2022 Oct; cited 2024 Sep 4]; Available from: https:\/\/www.ajovy.com\/globalassets\/ajovy\/ajovy-pi.pdf"},{"key":"e_1_3_5_14_1","unstructured":"Eli Lilly and Company. Emgality (galcanezumab-gnlm) prescribing information. US food and drug administration. 2018 [updated 2021 Mar; cited 2024 Sep 4]; Available from: https:\/\/uspl.lilly.com\/emgality\/emgality.html#pi"},{"key":"e_1_3_5_15_1","unstructured":"Lundbeck Seattle BioPharmaceuticals Inc. Vyepti (eptinezumab) prescribing information. US food and drug administration. 2020 [updated 2024 Aug; cited 2024 Sep 4]; Available from: https:\/\/www.lundbeck.com\/content\/dam\/lundbeck-com\/americas\/united-states\/products\/neurology\/vyepti_pi_us_en.pdf"},{"key":"e_1_3_5_16_1","unstructured":"Amgen Inc. Aimovig (erenumab) prescribing information. US food and drug administration. 2018 [updated 2024 Aug; cited 2024 Sep 4]; Available from: https:\/\/www.pi.amgen.com\/-\/media\/Project\/Amgen\/Repository\/pi-amgen-com\/Aimovig\/aimovig_pi_hcp_english.pdf"},{"key":"e_1_3_5_17_1","unstructured":"AbbVie Inc. Qulipta (atogepant) prescribing information. US food and drug administration. 2021 [updated 2023 Jun; cited 2024 Sep 9]; Available from: https:\/\/www.rxabbvie.com\/pdf\/QULIPTA_pi.pdf"},{"key":"e_1_3_5_18_1","unstructured":"Pfizer Inc. Vydura (rimegepant) summary of product characteristics. European Medicines Agency. 2022 [updated 2022 Apr; cited 2024 Sep 4]; Available from: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2022\/20220425155292\/anx_155292_en.pdf"},{"key":"e_1_3_5_19_1","unstructured":"Pfizer Inc. Vydura (rimegepant) summary of product characteristics (Great Britain Northern Ireland). Pfizer emc pi portal; 2022 [updated 2023 Aug; cited 2024 Sep 4]; Available from: https:\/\/www.pfizerpiindex.co.uk\/vydura#pi-1"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231219505"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231179131"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1337"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1230"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1244"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1088"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/25158163211007922"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13727"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2021.0250"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280213"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330109"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.127"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2013"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1940.01210040002001"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30185-1"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.03.010"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.05.016"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-020-01493-z"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1055-3"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2010.05.014"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01425-9"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811090"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31606-X"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00126-6"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S453806"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024221141686"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01731-4"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241238153"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241232944"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01897-2"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S453937"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13930"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00626-1"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01378-5"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S456006"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000576"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1205778"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273304677240529062909"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2177270"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03347-6"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00795"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01723-4"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231151419"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000001072"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01440-w"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2021.1945444"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28544"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.315991"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00997-1"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1701"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241269735"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-024-00586-w"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2223958"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2340932"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32544-7"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02369-x"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01852.x"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00562-w"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231152169"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231159366"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241235156"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14128"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0122"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-024-01345-3"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13959"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414550416"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024221143773"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420915167"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420938652"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.3698"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2365312"},{"key":"e_1_3_5_92_1","unstructured":"National Institute for Health and Care Excellence. Rimegepant for treating migraine. NICE guidance. 2023 Available from: https:\/\/www.nice.org.uk\/guidance\/ta919\/chapter\/1-Recommendations"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241252666"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14692"},{"key":"e_1_3_5_95_1","unstructured":"National Institute for Health and Care Excellence. Rimegepant for preventing migraine. NICE. 2023 [updated 2023 Jul; cited 2024 Sep 4]; Available from: https:\/\/www.nice.org.uk\/guidance\/ta906\/chapter\/1-Recommendations"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00544-2"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2024.2434079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:26:35Z","timestamp":1733469995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2024.2434079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":94,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1080\/14737175.2024.2434079"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2024.2434079","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}